Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Evogene Ltd
NASDAQ:EVGN
Evogene Ltd
NASDAQ:EVGN
Price:
0.3599
USD
-0.3%
Market Closed
Market Cap:
$4.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Evogene Ltd
NASDAQ:EVGN
|
IL |
|
NovaBridge Biosciences
F:0VY
|
US |
|
GlobeStar Therapeutics Corp
OTC:GSTC
|
US |
|
O
|
Old National Bancorp
F:ON1
|
US |
|
M
|
Mon Courtier Energie SAS
PAR:ALMCE
|
FR |
|
G
|
Givaudan SA
XMUN:GIN
|
CH |
|
Molinos Rio de la Plata SA
OTC:MOPLF
|
AR |
|
Meko AB
F:1OM
|
SE |
|
P
|
Poly Property Group Co Ltd
F:CMJ
|
HK |
|
Mizuno Corp
F:MIZ
|
JP |
|
F
|
Forcs Co Ltd
KOSDAQ:189690
|
KR |
|
Davictus PLC
LSE:DVT
|
MY |
|
R
|
Rigolleau SA
BCBA:RIGO
|
AR |
|
WisdomTree Inc
F:1WT
|
US |
|
La Francaise de l Energie SA
F:LFX
|
FR |
|
Shufersal Ltd
OTC:SHUFF
|
IL |
|
Promotora de Informaciones SA
MAD:PRS
|
ES |
|
T
|
Tocvan Ventures Corp
CNSX:TOC
|
CA |
Wall St Price Targets
EVGN Price Forecast
Based on 3 analysts
Based on 3 analysts
+509% Upside
from
$0.3599
today
Evogene Ltd (EVGN)’s 12-month stock price forecast through November 2027 has a consensus target of $2.193, implying 509% upside. The forecast is based on price targets from 3 Wall Street analysts.
EVGN Analyst Rating
Based on 1 analyst
Based on 1 analyst
The analyst rating for EVGN is Strong buy.
Evogene Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EVGN's stock price target?
Price Target
2.193
USD
2.193
USD
According to Wall Street analysts, the average 1-year price target for EVGN is 2.193 USD with a low forecast of 2.1715 USD and a high forecast of 2.2575 USD.
What is the Revenue forecast for Evogene Ltd?
Projected CAGR
9%
9%
Over the last 1 year, the compound annual growth rate for Revenue has been -31%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for Evogene Ltd?
Projected CAGR
82%
82%
Over the last 1 year, the compound annual growth rate for Gross Profit has been 39%. The projected CAGR for the next 3 years is 82%.
